-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
RVL Pharmaceuticals plc quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2022.
- RVL Pharmaceuticals plc Earnings Per Share, Basic for the quarter ending June 30, 2023 was -0.24 USD/shares, a 71.4% decline year-over-year.
- RVL Pharmaceuticals plc Earnings Per Share, Basic for the twelve months ending June 30, 2023 was -0.72 USD/shares, a 4% increase year-over-year.
- RVL Pharmaceuticals plc annual Earnings Per Share, Basic for 2022 was -0.58 USD/shares, a 39.6% increase from 2021.
- RVL Pharmaceuticals plc annual Earnings Per Share, Basic for 2021 was -0.96 USD/shares, a 26.7% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)